Novo Nordisk makes both Tresiba and Ozempic (semaglutide)
Recent multisociety practice guidelines have offered more clarity for clinicians who provide sedation outside the operating roomincluding dentists, endoscopists, and proceduralistswhen treating patients on GLP-1 receptor agonists (GLP-1 RAs) like Semaglutide, Ozempic, or Wegovy.sciencedirect Key Recommendations: Shared Decision-Making: Management should involve the patient and all relevant care teams (procedural, anesthesia, prescribing), considering metabolic needs and individual risk factors
GLP-1R KO can lead to increased appetite, contributing to weight gain
The ingredients in Lemme Reset have real research behind them, but any effects are modest at best and depend heavily on healthy lifestyle changes
These medications significantly reduce appetite and promote early satiety, naturally lowering calorie intake
Semaglutide can suppress appetite, which can make it hard to get proper nutrition